Strategic PR and marketing programme to raise awareness of the Company and its products and services, and to strengthen Horizon’s brand as the world’s leading gene editing and translational genomics company.
The program has needed to have the flexibility to adapt to changing needs as the Company has grown and developed, including in the run-up to and following listing on the AIM market of the London Stock Exchange, and around M&A activity
Client comments: “Zyme’s proactive approach and professionalism has served Horizon well as we have transitioned from being a small biotech on the Cambridge stage to the global leader in translational genomics and personalised medicine that we are today. Zyme has grown with us every step of the way.”
Vice President, Marketing, Horizon Discovery Group.